DOPAMINE RECEPTOR STIMULATING AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE

被引:0
|
作者
AGID, Y
BARROCHE, G
BONNET, AM
JAVOYAGID, F
KATO, G
LHERMITTE, F
POLLAK, P
SIGNORET, JL
机构
来源
BIOMEDICINE | 1979年 / 30卷 / 02期
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:67 / 71
页数:5
相关论文
共 50 条
  • [41] DOPAMINE CELL REPLACEMENT - PARKINSONS-DISEASE
    YUREK, DM
    SLADEK, JR
    ANNUAL REVIEW OF NEUROSCIENCE, 1990, 13 : 415 - 440
  • [42] PARKINSONS-DISEASE - BRAIN DOPAMINE RECEPTORS
    LEE, T
    SEEMAN, P
    RAJPUT, A
    FARLEY, I
    HORNYKIEWICZ, O
    FEDERATION PROCEEDINGS, 1978, 37 (03) : 382 - 382
  • [43] TREATMENT OF PARKINSONS-DISEASE WITH THE PARTIAL DOPAMINE AGONIST EMD 49980
    BRAVI, D
    DAVIS, TL
    MOURADIAN, MM
    CHASE, TN
    MOVEMENT DISORDERS, 1993, 8 (02) : 195 - 197
  • [44] EARLY COMBINATION OF DOPAMINE AGONIST AND LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    RINNE, UK
    MOUNT SINAI JOURNAL OF MEDICINE, 1988, 55 (02): : 138 - 141
  • [45] TREATMENT OF SEVERE PARKINSONS-DISEASE BY INTRAVENTRICULAR-INJECTION OF DOPAMINE
    VENNA, N
    SABIN, TD
    ORDIA, JI
    MARK, VH
    APPLIED NEUROPHYSIOLOGY, 1984, 47 (1-2) : 62 - 64
  • [46] INTRAVENTRICULAR INFUSION OF DOPAMINE IN PARKINSONS-DISEASE
    HORNE, MK
    BUTLER, EG
    GILLIGAN, BS
    WODAK, J
    STARK, RJ
    BRAZENOR, GA
    ANNALS OF NEUROLOGY, 1989, 26 (06) : 792 - 794
  • [47] MARKERS OF DOPAMINE METABOLISM IN PARKINSONS-DISEASE
    LEWITT, PA
    GALLOWAY, MP
    MATSON, W
    MILBURY, P
    MCDERMOTT, M
    SRIVASTAVA, DK
    OAKES, D
    NEUROLOGY, 1992, 42 (11) : 2111 - 2117
  • [48] DOPAMINE DEFICIENCY IN PARKINSONS-DISEASE - REPLY
    SCATTON, B
    JAVOYAGID, F
    AGID, Y
    NEUROLOGY, 1984, 34 (02) : 265 - 266
  • [49] PIRIBEDIL, A DOPAMINE AGONIST, IN PARKINSONS-DISEASE
    SWEET, RD
    WASTERLAIN, CG
    MCDOWELL, FH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (06) : 1077 - 1082
  • [50] DOPAMINE-RECEPTORS IN PARKINSONS-DISEASE
    HASSAN, MN
    THAKAR, JH
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (2-3): : 173 - 182